针对肝癌的向治疗:目前的状况和未来的方向
1School of Medicine, Shandong Xiehe University, 250000, China.
BioImpacts : BI
|February 20, 2026
概括
向治疗和免疫疗法为肝癌 (肝细胞癌) 提供了新的希望. 结合治疗方法和使用分子分析可以克服耐药性并改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 肝细胞癌 (HCC) 仍然是一个重大的全球健康挑战,原因是瘤异质性和对传统治疗的反应不佳.
- 现有的向疗法,如氨酸激酶抑制剂 (TKI),由于耐药性,长期有效性有限.
- 免疫治疗的进步,特别是免疫检查点抑制剂 (ICI),提供了新的治疗途径.
研究的目的:
- 审查肝癌向治疗方法的现状和进展.
- 分析分子过程,抵抗机制和组合疗法策略.
- 突出改善HCC治疗的新目标和方法.
主要方法:
- 综合文献综述,重点关注针对性疗法,免疫疗法和HCC的组合治疗.
- 对分子驱动因素,信号通路 (Wnt/β-catenin,PI3K/AKT/mTOR,RAS/RAF/MEK/ERK) 和抵抗机制的分析.
- 探索新兴目标 (FGFR4,AXL,c-MET) 和治疗策略,包括表观遗传调节剂和代谢脆弱性.
主要成果:
- 第一线TKIs (伦瓦提尼布,索拉费尼布) 提供适度的生存益处,但面临抵抗.
- 第二线药物 (regorafenib,cabozantinib,ramucirumab) 和与抗VEGF药物的联合疗法显示出有前途.
- 免疫检查点抑制剂 (阿特佐利祖马布,尼沃卢马布) 与抗VEGF疗法相结合,显示出令人鼓舞的结果.
- 了解瘤微环境和向致癌途径对于有效治疗至关重要.
结论:
- 组合疗法,包括ICI或辐射的向药物,对于克服耐药性至关重要.
- 动态分子分析和生物标记驱动的精密医学是患者分层和改善治疗决策的关键.
- 未来的进展在于肝细胞癌的个性化治疗策略,以实现持久的临床效果.
更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.6K
09:03Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
734
相关概念视频
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Cancer Vaccines
1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
